Naples Global Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.9M Sell
106,821
-1,154
-1% -$133K 0.94% 16
2025
Q4
$11.5M Buy
107,975
+57
+0.1% +$5.35K 0.86% 20
2025
Q3
$9.14M Buy
107,918
+990
+0.9% +$81.5K 0.71% 33
2025
Q2
$8.55M Buy
106,928
+5,768
+6% +$458K 0.74% 32
2025
Q1
$9.16M Buy
101,160
+2,981
+3% +$278K 0.87% 19
2024
Q4
$9.84M Buy
98,179
+1,784
+2% +$184K 0.92% 15
2024
Q3
$11M Buy
96,395
+1,476
+2% +$175K 1.02% 13
2024
Q2
$11.8M Sell
94,919
-622
-0.7% -$80.1K 1.19% 10
2024
Q1
$12.7M Sell
95,541
-278
-0.3% -$34.3K 1.3% 11
2023
Q4
$10.5M Sell
95,819
-228
-0.2% -$23.7K 1.16% 11
2023
Q3
$9.96M Buy
96,047
+2,317
+2% +$250K 1.21% 9
2023
Q2
$10.9M Sell
93,730
-1,026
-1% -$116K 1.28% 9
2023
Q1
$10.1M Sell
94,756
-678
-0.7% -$73.2K 1.27% 6
2022
Q4
$10.7M Sell
95,434
-730
-0.8% -$74.6K 1.35% 6
2022
Q3
$8.35M Buy
96,164
+1,130
+1% +$101K 1.15% 9
2022
Q2
$8.71M Buy
95,034
+1,338
+1% +$119K 1.13% 9
2022
Q1
$7.69M Buy
93,696
+1,798
+2% +$142K 0.89% 17
2021
Q4
$7.04M Buy
91,898
+3,161
+4% +$252K 0.82% 21
2021
Q3
$6.67M Buy
88,737
+3,082
+4% +$234K 0.88% 19
2021
Q2
$6.66M Buy
85,655
+543
+0.6% +$40.4K 0.93% 14
2021
Q1
$6.26M Buy
85,112
+3,749
+5% +$277K 0.95% 14
2020
Q4
$6.35M Buy
81,363
+535
+0.7% +$40.9K 1.07% 9
2020
Q3
$6.4M Buy
80,828
+3,953
+5% +$310K 1.25% 8
2020
Q2
$5.67M Buy
76,875
+7,114
+10% +$536K 1.22% 9
2020
Q1
$5.12M Sell
69,761
-704
-1% -$55.3K 1.34% 7
2019
Q4
$6.12M Buy
70,465
+562
+0.8% +$46.2K 1.28% 8
2019
Q3
$5.62M Buy
69,903
+687
+1% +$55.1K 1.31% 7
2019
Q2
$5.54M Buy
69,216
+4,436
+7% +$340K 1.35% 7
2019
Q1
$5.14M Buy
64,780
+2,858
+5% +$214K 1.31% 7
2018
Q4
$4.4M Buy
61,922
+4,054
+7% +$286K 1.25% 7
2018
Q3
$3.92M Buy
57,868
+1,603
+3% +$102K 1.04% 12
2018
Q2
$3.26M Buy
56,265
+3,087
+6% +$174K 0.92% 18
2018
Q1
$2.76M Buy
53,178
+4,603
+9% +$249K 0.82% 25
2017
Q4
$2.61M Buy
48,575
+6,180
+15% +$343K 0.77% 32
2017
Q3
$2.59M Buy
42,395
+1,648
+4% +$99.9K 0.86% 21
2017
Q2
$2.49M Buy
40,747
+1,687
+4% +$103K 0.88% 18
2017
Q1
$2.37M Buy
39,060
+2,695
+7% +$164K 0.85% 20
2016
Q4
$2.04M Buy
36,365
+208
+0.6% +$12.2K 0.8% 22
2016
Q3
$2.15M Buy
36,157
+4,506
+14% +$264K 0.84% 21
2016
Q2
$1.74M Buy
31,651
+1,179
+4% +$62.7K 0.71% 29
2016
Q1
$1.54M Sell
30,472
-131
-0.4% -$6.42K 0.64% 36
2015
Q4
$1.54M Buy
30,603
+2,149
+8% +$108K 0.75% 32
2015
Q3
$1.34M Buy
28,454
+8,388
+42% +$446K 0.69% 40
2015
Q2
$1.09M Buy
20,066
+3,871
+24% +$217K 0.52% 71
2015
Q1
$888K Buy
16,195
+6,095
+60% +$345K 0.42% 101
2014
Q4
$547K Buy
10,100
+1,200
+13% +$66.9K 0.29% 139
2014
Q3
$503K Buy
8,900
+524
+6% +$29.4K 0.3% 137
2014
Q2
$462K Buy
8,376
+105
+1% +$5.73K 0.27% 156
2014
Q1
$448K Buy
8,271
+944
+13% +$48.9K 0.27% 149
2013
Q4
$350K Buy
+7,327
New +$335K 0.23% 170

Other funds holding MRK

Naples Global Advisors's MRK Position: Q1 2026 in Review

Naples Global Advisors reduced its Merck (MRK) stake by 1.1% in Q1 2026, selling an estimated $133K and leaving 106,821 shares worth $12.9M. The position accounts for 0.94% of the portfolio, ranked #16.

Naples Global Advisors first reported a position in MRK in Q4 2013 and has held it in 50 quarters since. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Naples Global Advisors held 106,821 shares of Merck worth $12.9M as of Q1 2026.
  • Naples Global Advisors sold 1,154 Merck shares in Q1 2026, an estimated $133K.
  • Merck made up 0.94% of Naples Global Advisors's portfolio in Q1 2026, its #16 holding.
  • Naples Global Advisors first reported a position in Merck in Q4 2013 and has held it in 50 quarters since.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Naples Global Advisors's 13F filing for Q1 2026, filed 20 Apr 2026.